ABSTRACT NUMBER: ESOC2026A2401 OPTIMISING COPD MANAGEMENT TO REDUCE STROKE RISK: REAL-WORLD EVIDENCE SUPPORTING THE USE OF SINGLE INHALED TRIPLE THERAPY FOR SECONDARY PREVENTION
Meredith Donaldson, Carl Deaney · 2026
Read ABSTRACT NUMBER: ESOC2026A2401 OPTIMISING COPD MANAGEMENT TO REDUCE STROKE RISK: REAL-WORLD EVIDENCE SUPPORTING THE USE OF SINGLE INHALED TRIPLE THERAPY FOR SECONDARY PREVENTION by Meredith Donaldson, Carl Deaney (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146855.txt.
Description
Meredith Donaldson and Carl Deaney report a 2026 conference study on lung disease care and stroke risk in primary care. Bad lung flare-ups raise stroke and heart attack risk sharply in the months that follow. A single inhaler that carries three drugs may cut severe lung and heart events.
Near three hundred eighty lung patients were reviewed at one practice. About one in eight also carried stroke or a warning event on their record. Many of that group had frequent flare-ups in the past year. Most high-need patients already used the three-drug inhaler. The pair argue that tuning inhaler care is a changeable lever for cutting repeat stroke risk in patients who carry both illnesses.
Catalog record
| CREATOR | Meredith Donaldson, Carl Deaney |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |